After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NYSE and operates within the Drug Manufacturers – Specialty & Generic industry segment. The current market capitalization of Hims & Hers Health Inc is $8.54B. A total of 13.24 million shares were traded on the day, compared to an average of 28.15M shares.
In the most recent transaction, Boughton Soleil sold 2,631 shares of HIMS for 35.22 per share on Nov 24 ’25. After the transaction, the Chief Legal Officer now owns 153,225 company shares. In a previous transaction on Nov 24 ’25, Boughton Soleil bought 2,631 shares at 35.11 per share.
Among the insiders who sold shares, Okupe Oluyemi disposed of 23,187 shares on Nov 17 ’25 at a per-share price of $36.81. This resulted in the Chief Financial Officer holding 70,232 shares of HIMS after the transaction. In another insider transaction, Boughton Soleil sold 2,637 shares at $42.53 per share on Nov 10 ’25. Company shares held by the Chief Legal Officer now total 155,856.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, HIMS has a high of $72.98 and a low of $23.97.
As of this writing, HIMS has an earnings estimate of $0.05 per share for the current quarter. EPS was calculated based on a consensus of 12.0 estimates, with a high estimate of $0.15 per share and a lower estimate of -$0.04. The company reported an EPS of $0.11 in the last quarter
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. HIMS’s latest balance sheet shows that the firm has $247.27M in Cash & Short Term Investments as of fiscal 2021. There were $5.48M in debt and $79.22M in liabilities at the time. Its Book Value Per Share was $2.55, while its Total Shareholder’s Equity was $334.62M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for HIMS is Buy with a score of 3.21.
